Cardiovascular Function and Treatment in Beta-Thalassemia Major

Updated:Jun 18,2013
Science News-Banner_HeaderPON_ScienceNews_DiscussThis

Cardiovascular Function and Treatment in Beta-Thalassemia Major

Circ Journal Cover for Science News

  • Heart failure (HF) is  the most common cause of death in Thalassemia Major.
  • In patients with Beta-thalassemia Major, acute and chronic forms of heart failure require different treatment.
  • Life expectancy is extended with use of chelation therapy.

    Read the full article in Circulation
    Circulation. 2013: published online before print June 17, 2013, 10.1161/CIR.0b013e31821c7c64.

Science-News-Supporting-Materials_Header Science-News-Other-Resources-Header
Science News-Related-Science_Header 

Did you see these recent Commentaries?

Commentaries View All

Connect with AHA Science News


Science News View All

Network with over 31,000 Heart and Stroke Professionals

DS-5610 PON Banner 280X137
  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
    Join the AHA's Professional Online Network at    Login to AHA's Professional Online Network at